<dl class="row">
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Nakanishi M, Mizuno T, Mizokami F, Koseki T, Takahashi K, Tsuboi N, Katz M, Lee JK, Yamada S. Impact of pharmacist intervention for blood pressure control in patients with chronic kidney disease: A meta-analysis of randomized clinical trials. J Clin Pharm Ther. 2021 Feb;46(1):114-120. doi: 10.1111/jcpt.13262. Epub 2020 Sep 19. PMID: 32949161. 
  </ref>
  <a><pmid>PMID32949161   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Fleming JN, Gebregziabher M, Posadas A, Su Z, McGillicuddy JW, Taber DJ. Impact of a pharmacist-led, mHealth-based intervention on tacrolimus trough variability in kidney transplant recipients: A report from the TRANSAFE Rx randomized controlled trial. Am J Health Syst Pharm. 2021 Apr 4:zxab157. doi: 10.1093/ajhp/zxab157. Epub ahead of print. PMID: 33821958. 
  </ref>
  <a><pmid>PMID33821958   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Cypes IN, Prohaska ES, Melton BL. Pharmacist impact on medication dosing and billable coding accuracy in outpatients with chronic kidney disease. J Am Pharm Assoc (2003). 2021 Mar-Apr;61(2):e153-e158. doi: 10.1016/j.japh.2020.10.009. Epub 2020 Nov 5. PMID: 33160871. 
  </ref>
  <a><pmid>PMID33160871   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2021 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Suzuki H, Uchida S, Kashiwagura Y, Tanaka S, Yamauchi K, Kageyama S, Namiki N. Impact of community pharmacist-led intensive education on the control of serum phosphate levels in haemodialysis patients. Int J Clin Pharm. 2021 Feb;43(1):220-228. doi: 10.1007/s11096-020-01136-8. Epub 2020 Sep 21. PMID: 32955654. 
  </ref>
  <a><pmid>PMID32955654   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Alsheikh R, Johnson K, Dauenhauer A, Kadambi P. Impact of transplant pharmacists on length of stay and 30-day hospital readmission rate: a single-centre retrospective cohort study. Eur J Hosp Pharm. 2020 Dec 30:ejhpharm-2020-002421. doi: 10.1136/ejhpharm-2020-002421. Epub ahead of print. PMID: 33380430. 
  </ref>
  <a><pmid>PMID33380430   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2020 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Duwez M, Chanoine S, Lepelley M, Vo TH, Pluchart H, Mazet R, Allenet B, Pison C, Briault A, Saint-Raymond C, Camara B, Claustre J, Bedouch P. Clinical evaluation of pharmacists' interventions on multidisciplinary lung transplant outpatients' management: results of a 7-year observational study. BMJ Open. 2020 Nov 27;10(11):e041563. doi: 10.1136/bmjopen-2020-041563. PMID: 33247028; PMCID: PMC7703423. 
  </ref>
  <a><pmid>PMID33247028   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2018 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Al Raiisi F, Stewart D, Fernandez-Llimos F, Salgado TM, Mohamed MF, Cunningham
S. Clinical pharmacy practice in the care of Chronic Kidney Disease patients: a
systematic review. Int J Clin Pharm. 2019 Jun;41(3):630-666. doi:
10.1007/s11096-019-00816-4. Epub 2019 Apr 9. Review. 
  </ref>
  <a><pmid>PMID30963447   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2017. 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Choi KS, Lee E, Rhie SJ. Impact of pharmacists' interventions on physicians'
decision of a knowledge-based renal dosage adjustment system. Int J Clin Pharm.
2019 Apr;41(2):424-433. doi: 10.1007/s11096-019-00796-5. Epub 2019 Mar 12. 
  </ref>
  <a><pmid>PMID30864079   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2017 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Conliffe B, Figg L, Moffett P, Lauterwasser L, Parsons LB. Impact of a formal pharmacist-run oral antineoplastic monitoring program: A pilot study in an adult genitourinary oncology clinic. J Oncol Pharm Pract. 2019 Jun;25(4):777-786. doi: 10.1177/1078155217753889. Epub 2018 Jan 29. 
  </ref>
  <a><pmid>PMID29375014   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2017 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     James D, Lopez L. Impact of a pharmacist-driven education initiative on
treatment of asymptomatic bacteriuria. Am J Health Syst Pharm. 2019 Mar 11. pii: zxy081. doi: 10.1093/ajhp/zxy081. [Epub ahead of print] 
  </ref>
  <a><pmid>PMID30854546   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Gheewala PA, Peterson GM, Zaidi ST, Bereznicki L, Jose MD, Castelino RL. A
web-based training program to support chronic kidney disease screening by
community pharmacists. Int J Clin Pharm. 2016 Jun 21. [Epub ahead of print] 
  </ref>
  <a><pmid>PMID27329381   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Mei JP, Ali-Moghaddam A, Mueller BA. Survey of pharmacists’ antibiotic dosing recommendations for sustained low-efficiency dialysis. Int J Clin Pharm. 2016
Feb;38(1):127-34. 
  </ref>
  <a><pmid>PMID26499505   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2016 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Lalonde L, Quintana-Bárcena P, Lord A, Bell R, Clément V, Daigneault AM,
Legris MÈ, Letendre S, Mouchbahani M, Jouini G, Azar J, Martin É, Berbiche D,
Beaulieu S, Beaunoyer S, Bertin É, Bouvrette M, Charbonneau-Séguin N, Desrochers JF, Desforges K, Dumoulin-Charette A, Dupuis S, El Bouchikhi M, Forget R, Guay M,
Lemieux JP, Morin-Bélanger C, Noël I, Ricard S, Sauvé P, Ste-Marie Paradis F.
Community Pharmacist Training-and-Communication Network and Drug-Related Problems
in Patients With CKD: A Multicenter, Cluster-Randomized, Controlled Trial. Am J
Kidney Dis. 2017 Jun 26. pii: S0272-6386(17)30731-X. doi:
10.1053/j.ajkd.2017.05.008. [Epub ahead of print] 
  </ref>
  <a><pmid>PMID28663062   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Khan Mohammed A, Medarametla C, Rabbani MM, Prashanthi K. Role of a clinical
pharmacist in managing diabetic nephropathy: an approach of pharmaceutical care
plan. J Diabetes Metab Disord. 2015 Oct 26;14:82. doi: 10.1186/s40200-015-0213-7.
eCollection 2015. 
  </ref>
  <a><pmid>PMID26504769   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Quintana-Bárcena P, Lord A, Lizotte A, Berbiche D, Jouini G, Lalonde L.
Development and validation of criteria for classifying severity of drug-related
problems in chronic kidney disease: A community pharmacy perspective. Am J Health
Syst Pharm. 2015 Nov 1;72(21):1876-84. doi: 10.2146/ajhp140765. 
  </ref>
  <a><pmid>PMID26490822   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Patricia NJ, Foote EF. A pharmacy-based medication reconciliation and review
program in hemodialysis patients: a prospective study. Pharm Pract (Granada).
2016 Jul-Sep;14(3):785. Epub 2016 Sep 15. 
  </ref>
  <a><pmid>PMID27785165   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2015 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Al Hamarneh YN, Tsuyuki RT, Jones CA, Manns B, Tonelli M, Scott-Douglass N,
Jindal K, Tink W, Hemmelgarn BR. Effectiveness of Pharmacist Interventions on
Cardiovascular Risk in Patients With CKD: A Subgroup Analysis of the Randomized
Controlled R(x)EACH Trial. Am J Kidney Dis. 2018 Jan;71(1):42-51. doi:
10.1053/j.ajkd.2017.07.012. Epub 2017 Sep 12. 
  </ref>
  <a><pmid>PMID28912054   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Williams A, Crawford K, Manias E, Ellis C, Mullins K, Howe K, Kennedy E, Maney O, Mark T, Gregory D, Van Hardeveld E, Yip D, Low JK. Examining the preparation and ongoing support of adults to take their medications as prescribed in kidney transplantation. J Eval Clin Pract. 2015 Apr;21(2):180-6. doi: 10.1111/jep.12270. Epub 2014 Oct 16. PubMed PMID25318842. 
  </ref>
  <a><pmid>PMID25318842   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Pinelli, N. R., L. M. Clark, et al. (2014). "Pharmacist managed diabetes and cardiovascular risk reduction clinic in kidney transplant recipients: bridging the gap in care transition." Diabetes Res Clin Pract 106(3): e64-67. PMID25451909 
  </ref>
  <a><pmid>PMID25451909   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Selcuk A, Sancar M, Okuyan B, Demirtunc R, Izzettin FV. The potential role of clinical pharmacists in elderly patients during hospital admission. Pharmazie.2015 Aug;70(8):559-62. PubMed PMID: 26380527. 
  </ref>
  <a><pmid>PMID26380527   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2014 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Han J, Bhat S, Gowhari M, Gordeuk VR, Saraf SL. Impact of a Clinical Pharmacy Service on the Management of Patients in a Sickle Cell Disease Outpatient Center.
Pharmacotherapy. 2016 Nov;36(11):1166-1172. doi: 10.1002/phar.1834. Epub 2016 Oct
3. 
  </ref>
  <a><pmid>PMID27639254   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Keat CH, Sooaid NS, Yun CY, Sriraman M. Improving safety-related knowledge, attitude and practices of nurses handling cytotoxic anticancer drug: pharmacists' experience in a general hospital, Malaysia. Asian Pacific Journal of Cancer Prevention. 2013;14(1):69-73 
  </ref>
  <a><pmid>PMID23534806   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     St Peter WL, Wazny LD, Patel UD. New models of chronic kidney disease care including pharmacists: improving medication reconciliation and medication management. Curr Opin Nephrol Hypertens. 2013 Nov;22(6):656-62. doi: 10.1097/MNH.0b013e328365b364. Review. PubMed PMID: 24076556; PubMed Central PMCID: PMC4012859. 
  </ref>
  <a><pmid>PMID24076556   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Cabello-Muriel A, Gascón-Cánovas JJ, Urbieta-Sanz E, Iniesta-Navalón C. Effectiveness of pharmacist intervention in patients with chronic kidney disease. Int J Clin Pharm. 2014 Oct;36(5):896-903. doi: 10.1007/s11096-014-0001-3. Epub 2014 Aug 20. PubMed PMID: 25135803. 
  </ref>
  <a><pmid>PMID25135803   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Kondo Y, Ishitsuka Y, Shigemori E, Irikura M, Kadowaki D, Hirata S, Maemura T, Irie T. Awareness and current implementation of drug dosage adjustment by pharmacists in patients with chronic kidney disease in Japan: a web-based survey. BMC Health Serv Res. 2014 Dec 3;14:615. doi: 10.1186/s12913-014-0615-0. PubMed PMID: 25464858; PubMed Central PMCID: PMC4258280. 
  </ref>
  <a><pmid>PMID25464858   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Dempsey JT, Matta LS, Carter DM, Stevens CA, Stevenson LW, Desai AS, Cheng JW.
Assessment of Drug Therapy-Related Issues in an Outpatient Heart Failure
Population and the Potential Impact of Pharmacist-Driven Intervention. J Pharm
Pract. 2016 Apr 13. pii: 0897190016641491. [Epub ahead of print] 
  </ref>
  <a><pmid>PMID27080398   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Migliozzi DR, Zullo AR, Collins C, Elsaid KA. Achieving blood pressure control
among renal transplant recipients by integrating electronic health technology and
clinical pharmacy services. Am J Health Syst Pharm. 2015 Nov 15;72(22):1987-92.
doi: 10.2146/ajhp140810. 
  </ref>
  <a><pmid>PMID26541954   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2013 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Chen CC, Hsiao FY, Shen LJ, Wu CC. The cost-saving effect and prevention of
medication errors by clinical pharmacist intervention in a nephrology unit.
Medicine (Baltimore). 2017 Aug;96(34):e7883. doi: 10.1097/MD.0000000000007883. 
  </ref>
  <a><pmid>PMID28834903   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Aspinall SL, Cunningham FE, Zhao X, Boresi JS, Tonnu-Mihara IQ, Smith KJ, Stone RA, Good CB; ESA Clinic Study Group. Impact of pharmacist-managed erythropoiesis-stimulating agents clinics for patients with non-dialysis-dependent CKD. Am J Kidney Dis. 2012 Sep;60(3):371-9. 
  </ref>
  <a><pmid>PMID22633556   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Salgado TM, Moles R, Benrimoj SI, Fernandez-Llimos F. Pharmacists' interventions in the management of patients with chronic kidney disease: a systematic review. Nephrol Dial Transplant. 2012 Jan;27(1):276-92. doi: 10.1093/ndt/gfr287. Epub 2011 Jun 30. 
  </ref>
  <a><pmid>PMID21719712   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Penm J, Li Y, Zhai S, Hu Y, Chaar B, Moles R. The impact of clinical pharmacy services in China on the quality use of medicines: a systematic review in context of China's current healthcare reform. Health Policy Plan. 2014 Oct;29(7):849-872.Epub 2013 Sep 19. Review. PubMed PMID: 24056897 
  </ref>
  <a><pmid>PMID24056897   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Aspinall SL, Smith KJ, Good CB, Zhao X, Stone RA, Tonnu-Mihara IQ, Cunningham FE. Incremental cost effectiveness of pharmacist-managed erythropoiesis-stimulating agent clinics for non-dialysis-dependent chronic kidney disease patients. Appl Health Econ Health Policy. 2013 Dec;11(6):653-60. doi: 10.1007/s40258-013-0057-6. PubMed PMID: 24092553. 
  </ref>
  <a><pmid>PMID24092553   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Jiang SP, Xu YY, Ping-Yang, Wu WF, Zhang XG, Lu XY, Xiao YH, Liang WF, Chen J. Improving antimicrobial dosing in critically ill patients receiving continuous venovenous hemofiltration and the effect of pharmacist dosing adjustment. Eur J Intern Med. 2014 Dec;25(10):930-5. doi: 10.1016/j.ejim.2014.08.001. Epub 2014 Aug 18. PubMed PMID: 25153537. 
  </ref>
  <a><pmid>PMID25153537   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Barnes KD, Tayal NH, Lehman AM, Beatty SJ. Pharmacist-driven renal medication dosing intervention in a primary care patient-centered medical home. Pharmacotherapy. 2014 Dec;34(12):1330-5. doi: 10.1002/phar.1508. Epub 2014 Oct 25. PubMed PMID: 25346347. 
  </ref>
  <a><pmid>PMID25346347   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Cooney D, Moon H, Liu Y, Miller RT, Perzynski A, Watts B, Drawz PE. A pharmacist based intervention to improve the care of patients with CKD: a pragmatic, randomized, controlled trial. BMC Nephrol. 2015 Apr 16;16:56. doi: 10.1186/s12882-015-0052-2. PubMed PMID: 25881226; PubMed Central PMCID: PMC4405859. 
  </ref>
  <a><pmid>PMID25881226   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Gheewala PA, Peterson GM, Curtain CM, Nishtala PS, Hannan PJ, Castelino RL. Impact of the pharmacist medication review services on drug-related problems and potentially inappropriate prescribing of renally cleared medications in residents of aged care facilities. Drugs Aging. 2014 Nov;31(11):825-35. doi: 10.1007/s40266-014-0208-y. PubMed PMID: 25187228. 
  </ref>
  <a><pmid>PMID25187228   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     El Borolossy R, El Wakeel L, El Hakim I, Badary O. Implementation of clinical pharmacy services in a pediatric dialysis unit. Pediatr Nephrol. 2014 Jul;29(7):1259-64. doi: 10.1007/s00467-014-2760-4. Epub 2014 Feb 16. PubMed PMID: 24531662 
  </ref>
  <a><pmid>PMID24531662   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2012 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Ghimirey A, Sapkota B, Shrestha S, Basnet N, Shankar PR, Sapkota S. Evaluation
of pharmacist counseling in improving knowledge, attitude, and practice in
chronic kidney disease patients. SAGE Open Med. 2013 Dec 18;1:2050312113516111.
doi: 10.1177/2050312113516111. eCollection 2013. 
  </ref>
  <a><pmid>PMID26770695   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Ko GT, Yeung CY, Leung WY, Chan KW, Chung CH, Fung LM, Ip TP, Kum G, Lau KP, Lau IT, Li JK, Siu SC, Tsang MW, Yeung VT, Tong PC, So WY, Chan JC. Cost implication of team-based structured versus usual care for type 2 diabetic patients with chronic renal disease. Hong Kong Med J. 2011 Dec;17 Suppl 6:9-12 
  </ref>
  <a><pmid>PMID22147352   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Ohnishi J, Miyake A, Kuwatsuka K, Onoue Y, Lee M, Koyama T, Sendo T, Kawasaki H, Kitamura Y. Effect of pharmacist management on serum hemoglobin levels with renal anemia in hemodialysis outpatients. Biol Pharm Bull. 2011;34(10):1609-12. 
  </ref>
  <a><pmid>PMID21963503   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Legris MÈ, Séguin NC, Desforges K, Sauvé P, Lord A, Bell R, Berbiche D, Desrochers JF, Lemieux JP, Morin-Bélanger C, Ste-Marie Paradis F, Lalonde L. Pharmacist Web-based training program on medication use in chronic kidney disease patients: impact on knowledge, skills, and satisfaction. J Contin Educ Health Prof. 2011 Summer;31(3):140-50. doi: 10.1002/chp.20119. 
  </ref>
  <a><pmid>PMID21953653   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     St Peter WL, Farley TM, Carter BL. Role of collaborative care models including pharmacists in improving blood pressure management in chronic kidney disease patients. Curr Opin Nephrol Hypertens. 2011 Sep;20(5):498-503. doi: 10.1097/MNH.0b013e32834902c8. 
  </ref>
  <a><pmid>PMID21709550   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Stemer G, Lemmens-Gruber R. Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature review. BMC Nephrol. 2011 Jul 22;12:35. doi: 10.1186/1471-2369-12-35. Review. 
  </ref>
  <a><pmid>PMID21777480   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Finks SW, Rogers KC, Manguso AH. Assessment of sotalol prescribing in a community hospital: opportunities for clinical pharmacist involvement. Int J Pharm Pract. 2011 Aug;19(4):281-6. doi: 10.1111/j.2042-7174.2011.00094.x. Epub 2011 Mar 15. 
  </ref>
  <a><pmid>PMID21733016   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Sánchez-Gili M, Toro-Chico P, Pérez-Encinas M, Gómez-Pedrero AM, Portolés-Pérez JM. [Pharmaceutical intervention on the therapeutic adherence in patients with chronic renal disease]. Rev Calid Asist. 2011 May-Jun;26(3):146-51. doi: 10.1016/j.cali.2010.11.012. Epub 2011 Mar 23. Spanish. 
  </ref>
  <a><pmid>PMID21435928   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Peterson JF, Kripalani S, Danciu I, Harrell D, Marvanova M, Mixon AS, Rodriguez C, Powers JS. Electronic surveillance and pharmacist intervention for vulnerable older inpatients on high-risk medication regimens. J Am Geriatr Soc. 2014 Nov;62(11):2148-52. doi: 10.1111/jgs.13057. Epub 2014 Nov 3. PubMed PMID: 25366414; PubMed Central PMCID: PMC4337022 
  </ref>
  <a><pmid>PMID25366414   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Jang SM, Cerulli J, Grabe DW, Fox C, Vassalotti JA, Prokopienko AJ, Pai AB. NSAID-avoidance education in community pharmacies for patients at high risk for acute kidney injury, upstate New York, 2011. Prev Chronic Dis. 2014 Dec 18;11:E220. doi: 10.5888/pcd11.140298. PubMed PMID: 25523351; PubMed Central PMCID: PMC4273546. 
  </ref>
  <a><pmid>PMID25523351   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Jiang SP, Zhu ZY, Wu XL, Lu XY, Zhang XG, Wu BH. Effectiveness of pharmacist dosing adjustment for critically ill patients receiving continuous renal replacement therapy: a comparative study. Ther Clin Risk Manag. 2014 Jun 3;10:405-12. doi: 10.2147/TCRM.S59187. eCollection 2014. PubMed PMID: 24940066; PubMed Central PMCID: PMC4051794. 
  </ref>
  <a><pmid>PMID24940066   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Geerts AF, De Koning FH, De Vooght KM, Egberts AC, De Smet PA, van Solinge WW. Feasibility of point-of-care creatinine testing in community pharmacy to monitor drug therapy in ambulatory elderly patients. J Clin Pharm Ther. 2013 Oct;38(5):416-22. doi: 10.1111/jcpt.12081. Epub 2013 Jun 28. PubMed PMID: 23808548. 
  </ref>
  <a><pmid>PMID23808548   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Via-Sosa MA, Lopes N, March M. Effectiveness of a drug dosing service provided by community pharmacists in polymedicated elderly patients with renal impairment--a comparative study. BMC Fam Pract. 2013 Jul 13;14:96. doi: 10.1186/1471-2296-14-96. PubMed PMID: 23849005; PubMed Central PMCID: PMC3723832. 
  </ref>
  <a><pmid>PMID23849005   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2011 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Meyenburg LK, Crannage AJ, Murphy JA, Korobey MJ. Evaluation of a Pharmacy-Managed Pharmacokinetic Dosing Program. J Pharm Pract. 2014 Aug 8. pii: 0897190014544825. [Epub ahead of print] PubMed PMID: 25107423. 
  </ref>
  <a><pmid>PMID25107423   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     AbuRuz SM, Alrashdan Y, Jarab A, Jaber D, Alawwa IA. Evaluation of the impact of pharmaceutical care service on hospitalized patients with chronic kidney disease in Jordan. Int J Clin Pharm. 2013 Oct;35(5):780-9. doi: 10.1007/s11096-013-9806-8. Epub 2013 Jul 25. PubMed PMID: 23884609. 
  </ref>
  <a><pmid>PMID23884609   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2010 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Mousavi M, Dashti-Khavidaki S, Khalili H, Farshchi A, Gatmiri M. Impact of clinical pharmacy services on stress ulcer prophylaxis prescribing and related cost in patients with renal insufficiency. Int J Pharm Pract. 2013 Aug;21(4):263-9. doi: 10.1111/ijpp.12005. Epub 2012 Nov 9. PubMed PMID: 23418812. 
  </ref>
  <a><pmid>PMID23418812   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bacchus S, O'Mara N, Manley H, Fishbane S. Meeting new challenges in the management of anemia of chronic kidney disease through collaborative care with pharmacists. Ann Pharmacother. 2009 Nov;43(11):1857-66. doi: 10.1345/aph.1M035.
Epub 2009 Oct 13. Review. 
  </ref>
  <a><pmid>PMID19826095   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Hassan Y, Al-Ramahi RJ, Aziz NA, Ghazali R. Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease. Ann Pharmacother. 2009 Oct;43(10):1598-605. doi: 10.1345/aph.1M187. Epub 2009 Sep 23. 
  </ref>
  <a><pmid>PMID19776297   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Mirkov S. Implementation of a pharmacist medication review clinic for haemodialysis patients. N Z Med J. 2009 Jun 19;122(1297):25-37. 
  </ref>
  <a><pmid>PMID19648999   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Pai AB, Boyd A, Chavez A, Manley HJ. Health-related quality of life is maintained in hemodialysis patients receiving pharmaceutical care: a 2-year randomized, controlled study. Hemodial Int. 2009 Jan;13(1):72-9. doi:10.1111/j.1542-4758.2009.00328.x. 
  </ref>
  <a><pmid>PMID19210281   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Pai AB, Boyd A, Depczynski J, Chavez IM, Khan N, Manley H. Reduced drug use and hospitalization rates in patients undergoing hemodialysis who received
pharmaceutical care: a 2-year, randomized, controlled study. Pharmacotherapy. 2009 Dec;29(12):1433-40. doi: 10.1592/phco.29.12.1433. 
  </ref>
  <a><pmid>PMID19947803   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Benammar MN, Laederic J, Roos, Tacco F, Durand JL, Mery D. Cloxacilline et insuffisance rénale sévère ; intérêt d’un suivi thérapeutique pharmacologique. Pharm Hosp. 2009;44 :88-90. 
  </ref>
  <a><pmid>LID191   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Salgado TM, Correr CJ, Moles R, Benrimoj SI, Fernandez-Llimos F. Assessing the implementability of clinical pharmacist interventions in patients with chronic kidney disease: an analysis of systematic reviews. Ann Pharmacother. 2013 Nov;47(11):1498-506. doi: 10.1177/1060028013501802. Epub 2013 Sep 27. Review. PubMed PMID: 24259596 
  </ref>
  <a><pmid>PMID24259596   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2009 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Vessal G. Detection of prescription errors by a unit-based clinical pharmacist
in a nephrology ward. Pharm World Sci. 2010 Feb;32(1):59-65. doi:
10.1007/s11096-009-9341-9. Epub 2009 Oct 17. 
  </ref>
  <a><pmid>PMID19838816   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Chisholm-Burns MA, Spivey CA, Garrett C, McGinty H, Mulloy LL. Impact of clinical pharmacy services on renal transplant recipients' adherence and outcomes. Patient Prefer Adherence. 2008 Feb 2;2:287-92. PubMed PMID: 19920975; PubMed Central PMCID: PMC2770420. 
  </ref>
  <a><pmid>PMID19920975   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Lalonde L, Normandeau M, Lamarre D, Lord A, Berbiche D, Corneille L, Prud'homme L, Laliberté MC. Evaluation of a training and communication-network nephrology program for community pharmacists. Pharm World Sci. 2008Dec;30(6):924-33. doi: 10.1007/s11096-008-9253-0. Epub 2008 Sep 19. 
  </ref>
  <a><pmid>PMID18802782   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Leung M, Jung J, Lau W, Kiaii M, Jung B. Best possible medication history for hemodialysis patients obtained by a pharmacy technician. Can J Hosp Pharm. 2009
Sep;62(5):386-91. 
  </ref>
  <a><pmid>PMID22478921   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2008 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     So TY, Layton JB, Bozik K, Farrington E, Gipson PE, Gibson K, Primack W,
Conley W 3rd, Gipson DS, Ferris M. Cognitive pharmacy services at a pediatric
nephrology and hypertension clinic. Ren Fail. 2011;33(1):19-25. doi:
10.3109/0886022X.2010.536291. 
  </ref>
  <a><pmid>PMID21219201   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2007 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Allenet B, Chen C, Romanet T, Vialtel P, Calop J. Assessing a pharmacist-run anaemia educational programme for patients with chronic renal insufficiency. Pharm World Sci. 2007 Feb;29(1):7-11. 
  </ref>
  <a><pmid>PMID17268940   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2007 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Gilmartin C. Pharmacist's role in managing anemia in patients with chronic kidney disease: potential clinical and economic benefits. Am J Health Syst Pharm. 2007 Jul 1;64(13 Suppl 8):S15-22; quiz S23-5. Review. 
  </ref>
  <a><pmid>PMID17591991   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2007 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Ledger S, Choma G. Medication reconciliation in hemodialysis patients. CANNT J. 2008 Oct-Dec;18(4):41-3. 
  </ref>
  <a><pmid>PMID19175192   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2007 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Gallagher H, de Lusignan S, Harris K, Cates C. Quality-improvement strategies for the management of hypertension in chronic kidney disease in primary care: a systematic review. Br J Gen Pract. 2010 Jun;60(575):e258-65. doi: 10.3399/bjgp10X502164. Review. PubMed PMID: 20529489; PubMed Central PMCID: PMC2880767. 
  </ref>
  <a><pmid>PMID20529489   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2006 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bucaloiu ID, Akers G, Bermudez MC, Mainali R, Brown BL, Roberts SS, Hartle JE. Outpatient erythropoietin administered through a protocol-driven, pharmacist-managed program may produce significant patient and economic benefits. Manag Care Interface. 2007 Jun;20(6):26-30. 
  </ref>
  <a><pmid>PMID17708080   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2005 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Donovan JL, Schroeder WS, Tran MT, Foster K, Forrest A, Lee TB, Gandhi PJ. Assessment of eptifibatide dosing in renal impairment before and after in-service education provided by pharmacists. J Manag Care Pharm. 2007 Sep;13(7):598-606. 
  </ref>
  <a><pmid>PMID17874866   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2004 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Kimura T, Arai M, Masuda H, Kawabata A. Impact of a pharmacist-implemented anemia management in outpatients with end-stage renal disease in Japan. Biol Pharm Bull. 2004 Nov;27(11):1831-3. 
  </ref>
  <a><pmid>PMID15516732   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2004 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Farrell B, Pottie K, Hogg W. Case report: adverse drug reactions in unrecognized kidney failure. Can Fam Physician. 2004 Oct;50:1385-7. 
  </ref>
  <a><pmid>PMID15526875   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2004 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Walton T, Holloway K, Knauss M. Pharmacist-managed anemia program in an outpatient hemodialysis population. Hosp Pharm. 2005;(40):1051-56 
  </ref>
  <a><pmid>LID77   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2004 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Deuster S, Roten I, Muehlebach S. Implementation of treatment guidelines to
support judicious use of antibiotic therapy. J Clin Pharm Ther. 2010
Feb;35(1):71-8. doi: 10.1111/j.1365-2710.2009.01045.x. 
  </ref>
  <a><pmid>PMID20175814   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2002 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Viola RA, Abbott KC, Welch PG, McMillan RJ, Sheikh AM, Yuan CM. A multidisciplinary program for achieving lipid goals in chronic hemodialysis patients. BMC Nephrol. 2002 Nov 14;3:9. 
  </ref>
  <a><pmid>PMID12431277   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2002 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Bedouch P, Allenet B, Labarere J, Brudieu E, Chen C, Chevrot D, Tessier A,
Trivin C, Rousseau A, Calop J. [Diffusion of pharmacist interventions within the framework of clinical pharmacy activity in the clinical ward]. Therapie. 2005
Sep-Oct;60(5):515-22. French. 
  </ref>
  <a><pmid>PMID16433018   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2001 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Falconnier AD, Haefeli WE, Schoenenberger RA, Surber C, Martin-Facklam M. Drug dosage in patients with renal failure optimized by immediate concurrent feedback. J Gen Intern Med. 2001 Jun;16(6):369-75. 
  </ref>
  <a><pmid>PMID11422633   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2001 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     To LL, Stoner CP, Stolley SN, Buenviaje JD, Ziegler TW. Effectiveness of a pharmacist-implemented anemia management protocol in an outpatient hemodialysis unit. Am J Health Syst Pharm. 2001 Nov 1;58(21):2061-5. 
  </ref>
  <a><pmid>PMID11715828   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     2001 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Quercia RA, Abrahams R, White CM et al. Cost avoidance and clinical benefits derived from a pharmacy-managed anemia program. Hosp Pharm. 2001; 36: 169–175 
  </ref>
  <a><pmid>LID76   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1997 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Grabe DW, Low CL, Bailie GR, Eisele G. Evaluation of drug-related problems in an outpatient hemodialysis unit and the impact of a clinical pharmacist. Clin Nephrol. 1997 Feb;47(2):117-21. 
  </ref>
  <a><pmid>PMID9049460   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1996 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Andersen SR, St Peter JV, Macres MG, St Peter WL. Accuracy of technicians versus pharmacists in checking syringes prepared for a dialysis program. Am J Health Syst Pharm. 1997 Jul 15;54(14):1611-3. 
  </ref>
  <a><pmid>PMID9248604   </pmid></a> 
</dd> 
<dt class="col-md-1">
  <ref_annee> 
     1994 
  </ref_annee> 
</dt>
<dd class="col-md-11">
  <ref> 
     Kaplan B, Shimp LA, Mason NA, Ascione FJ. Chronic hemodialysis patients - Part II: Reducing drug-related problems through application of the focused drug therapy review program. Ann Pharmacother. 1994 Mar;28(3):320-4. 
  </ref>
  <a><pmid>PMID8193417   </pmid></a> 
</dd> 
</dl>